Skip to main content

Market Overview

12 Healthcare Stocks Moving In Monday's Pre-Market Session

Share:

Gainers

  • Eyenovia (NASDAQ:EYEN) stock surged 13.56% to $3.85 during Monday's pre-market session. The company's market cap stands at $76.1 million.
  • Immuron (NASDAQ:IMRN) stock surged 13.11% to $8.8. The market value of their outstanding shares is at $38.9 million.
  • OncoSec Medical (NASDAQ:ONCS) stock moved upwards by 12.35% to $4.0. The market value of their outstanding shares is at $91.0 million.
  • Humanigen (NASDAQ:HGEN) stock moved upwards by 9.95% to $13.47. The company's market cap stands at $1.7 billion.
  • Ovid Therapeutics (NASDAQ:OVID) stock surged 9.71% to $6.2. The company's market cap stands at $339.4 million.
  • Immatics (NASDAQ:IMTX) stock surged 9.46% to $12.84.

 

 

Losers

  • Avenue Therapeutics (NASDAQ:ATXI) shares fell 54.72% to $5.0 during Monday's pre-market session. The company's market cap stands at $83.4 million.
  • Fortress Biotech (NASDAQ:FBIO) shares declined by 30.22% to $2.91. The company's market cap stands at $239.9 million.
  • Genfit (NASDAQ:GNFT) stock declined by 10.29% to $4.27. The market value of their outstanding shares is at $165.8 million.
  • Medigus (NASDAQ:MDGS) stock fell 8.34% to $1.76. The company's market cap stands at $10.3 million.
  • Checkpoint Therapeutics (NASDAQ:CKPT) shares fell 8.13% to $2.6. The company's market cap stands at $143.1 million.
  • Artelo Biosciences (NASDAQ:ARTL) stock decreased by 5.9% to $0.81. The company's market cap stands at $2.7 million.

 

 

 

Related Articles (ARTL + ATXI)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversPre-Market Outlook Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com